Metabolic associated fatty liver disease increases risk of adverse events after acute coronary syndrome

被引：0
|
作者：
Chew, N. [1 ]
Ng, C. H. [2 ]
Kong, G. [2 ]
Chin, Y. H. [2 ]
Lim, O. [3 ]
Lim, W. H. [3 ]
Dalakoti, M. [3 ]
Khoo, C. M. [2 ]
Kong, W. [1 ]
Poh, K. K. [1 ]
Foo, R. [1 ]
Lee, C. H. [1 ]
Chan, M. Y. [1 ]
Muthiah, M. [2 ]
Loh, P. H. [1 ]
机构：
[1] Natl Univ Heart Ctr, Singapore, Singapore
[2] Natl Univ Hlth Syst, Singapore, Singapore
[3] Natl Univ Singapore, Singapore, Singapore
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1414 / 1414
页数：1
相关论文
共 50 条
  • [21] Metabolic-associated fatty liver disease and the risk of cardiovascular disease
    Zhang, Pengwei
    Dong, Xianhui
    Zhang, Wei
    Wang, Shiyin
    Chen, Chen
    Tang, Jiake
    You, Yao
    Hu, Siqi
    Zhang, Shenghui
    Wang, Chunyi
    Wen, Wen
    Zhou, Mengyun
    Tan, Tao
    Qi, Guanming
    Li, Li
    Wang, Mingwei
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (01)
  • [22] METABOLIC ASSOCIATED FATTY LIVER DISEASE IS HIGHLY PREVALENT IN THE POST-ACUTE COVID SYNDROME
    Raggi, P.
    Barbieri, S.
    Milic, J.
    Gozzi, L.
    Brigo, A.
    Beghe', B.
    Verduri, A.
    Clini, E.
    Mussini, C.
    Sebastiani, G.
    Guaraldi, G.
    ATHEROSCLEROSIS, 2022, 355 : E169 - E170
  • [23] Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
    Campos-Murguia, Alejandro
    Monserrat Roman-Calleja, Berenice
    Vicente Toledo-Coronado, Israel
    Alberto Gonzalez-Regueiro, Jose
    Adrian Solis-Ortega, Alberto
    Kusulas-Delint, Deyanira
    Cruz-Contreras, Mariana
    Cruz-Yedra, Nabila
    Javier Cubero, Francisco
    Alexandrowna Nevzorova, Yulia
    Fernando Martinez-Cabrera, Carlos
    Moreno-Guillen, Paulina
    Arturo Lozano-Cruz, Oscar
    Chapa-Ibarguengoitia, Monica
    Gulias-Herrero, Alfonso
    Alberto Aguilar-Salinas, Carlos
    Ruiz-Margain, Astrid
    Ulises Macias-Rodriguez, Ricardo
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (05) : 525 - 533
  • [24] Is Adverse Coronary Anatomy Associated with Heart Failure After an Acute Coronary Syndrome?
    Koh, Angela
    Tan, Julian
    Guo, Kenneth
    Kwok, Veronica
    Teo, Tina
    Chia, Stanley
    Wong, Aaron
    Lim, Soo Teik
    Koh, Tian Hai
    Tan, Jack
    CIRCULATION, 2010, 122 (02) : E247 - E247
  • [25] Metabolic Syndrome Exponentially Increases the Risk of Adverse Outcomes after Surgery for Diverticulitis
    Jehan, Faisal
    Zeeshan, Muhammad
    Zakaria, El Rasheid
    Hamidi, Mohammad
    Gries, Lynn M.
    Tang, Andrew L.
    O'Keeffe, Terence
    Kulvatunyou, Narong
    Joseph, Bellal
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S69 - S70
  • [26] NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH CARDIOVASCULAR RISK FACTORS OF METABOLIC SYNDROME
    Hurjui, Daniela Maria
    Nita, Otilia
    Graur, Lidia Iuliana
    Mihalache, Laura
    Popescu, Dana Stefana
    Hutanasu, I. C.
    Ungureanu, Didona
    Graur, Mariana
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (03): : 692 - 699
  • [27] Risk scores in predicting adverse events following acute coronary syndrome Comment
    Templin, Christian
    Di Vece, Davide
    LANCET, 2021, 397 (10270): : 172 - 173
  • [28] The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome
    Noda, Takumi
    Kamiya, Kentaro
    Hamazaki, Nobuaki
    Nozaki, Kohei
    Ichikawa, Takafumi
    Yamashita, Masashi
    Uchida, Shota
    Maekawa, Emi
    Terada, Tasuku
    Reed, Jennifer L.
    Yamaoka-Tojo, Minako
    Matsunaga, Atsuhiko
    Ako, Junya
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [29] NON ALCOHOLIC FATTY LIVER DISEASE IN INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH FEWER RISK FACTORS FOR METABOLIC SYNDROME
    Glassner, Kerri
    Oglat, Ayah
    Malaty, Hoda M.
    Victor, David
    Abraham, Bincy
    GASTROENTEROLOGY, 2017, 152 (05) : S779 - S779
  • [30] Review article: the treatment of fatty liver disease associated with the metabolic syndrome
    Marchesini, G
    Natale, S
    Manini, R
    Agostini, F
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 : 37 - 39
12345